Showing results (1111-1120 of 3,105) with videos related to
Sort By:
Pageof 311
Drug Safety|March 28, 2008
A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleedingIan S Fraser, Robert J Porte, Peter A Kouides, et al.Drug Safety|March 28, 2008
Propofol infusion syndrome: an overview of a perplexing diseaseVincenzo Fodale, Enza La MonacaDrug Safety|March 28, 2008
Adequacy of patient information on adverse effects: an assessment of patient information leaflets in the UKNeil Carrigan, D K Raynor, Peter KnappDrug Safety|March 28, 2008
Hepatic effects of lovastatin exposure in patients with liver disease: a retrospective cohort studyAndrew L Avins, Michele M Manos, Lynn Ackerson, et al.Drug Safety|March 28, 2008
Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorderMark E Bangs, Ling Jin, Shuyu Zhang, et al.Drug Safety|November 6, 1998
A risk-benefit assessment of epoetin in the management of anaemia associated with cancerY BeguinDrug Safety|November 6, 1998
A risk-benefit assessment of pharmacotherapy for anxiety disorders in children and adolescentsS M Hawkridge, D J SteinDrug Safety|November 6, 1998
Treating gastro-oesophageal reflux disease during pregnancy and lactation: what are the safest therapy options?C N Broussard, J E RichterDrug Safety|November 24, 1998
Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?M Ostensen, R Ramsey-GoldmanPageof 311